By Rory McCann, Marketing Manager & Conference Producer, LSN
In this interview, I sit down to chat with Dr. Jeff Livingstone on his recent move to CEO of Igia Pharmaceuticals, and how partnering events continue to serve his companies, even as an industry veteran. Jeff shares insight into the early days of Igia, and how he uses partnering to expand their goals and reach children and families affected by rare and orphan diseases, specifically Noonan Syndrome.
| An Interview with Dennis Ford, CEO, LIfe Science Nation
By Rory McCann, Marketing Manager & Conference Producer, LIfe Science Nation |
It’s no secret that while the traditional partnering and event model has taken a hit this year, life-saving deal-making is still in full swing. In fact, the need for innovation in life science and healthcare may be the key to a return to normalcy. As we round the corner into 2021, digital partnering conferences dot the landscape of what remains an unknown future. Armed with more data and a better understanding of what successful digital partnering looks like than we had six months ago, I sat down to speak with Life Science Nation (LSN) CEO, Dennis Ford on what makes the LSN partnering experience stand out, as well as the hidden value that makes all the difference.
Listen below to find out more about RESI Partnering Platforms
To learn more and sign up for Digital RESI November, visit http://www.resiconference.com. Explore LSN’s upcoming Healthtech Partnering Week at www.healthtechpartneringweek.com.
 Dr. Mary Furlong |
An Interview with Dr. Mary Furlong, President and CEO, Mary Furlong and Associates By Rory McCann, Marketing Manager & Conference Producer, LSN |
With our inaugural Longevity, Health & Innovation conference fast approaching, I spoke to Dr. Mary Furlong, President and CEO of Mary Furlong and Associates, our partner for LHI. MFA is widely considered a leader in the longevity and aging marketplace, largely due to Mary’s experience in the space.
Listen below to find out more about how Mary got started, where she thinks the industry is going and the importance of events such as LHI in moving technologies and solutions forward.
Mary Furlong, Ed.D, MFA’s president and CEO, is a leading authority on the longevity marketplace. She has guided the business development and marketing strategies of leading corporations, emerging companies, and nonprofit organizations for more than 30 years.
Her list of clients/sponsors includes AARP, Caring.com, CareLinx, First Republic Bank, GreatCall Inc., Link•age, PetPlan, and UnitedHealthcare (UHC). Mary founded MFA in 2003 to help socially- and consumer-conscious companies understand the real needs of this growing market.
In addition, Mary is the Dean’s Executive Professor of Entrepreneurship at Santa Clara University’s Leavey School of Business.
Before launching MFA, Mary founded the nonprofit organization SeniorNet in 1986 and ThirdAge Media in 1996. Throughout the course of her work for both organizations, she raised $130 million in venture capital funds, corporate sponsorships, and foundation grants.
During Mary’s tenure, SeniorNet served more than 500,000 adults age 50 and older. Much of her time was spent in the field at the organization’s learning centers, observing the applications that worked and the issues related to the technology. ThirdAge Media reached more than 2 million members – most age 45 and older – when Mary served as its CEO and visionary leader of the editorial team.
Mary has appeared on CBS, PBS, NPR, and NBC’s Today show to discuss trends in aging and technology, and her expertise has been featured in The New York Times, USA Today, Business Week, Fortune, People, and Fast Company, among other publications.
In 2001, Fortune Small Business named Mary one of its “Top 25 Women Entrepreneurs,” and Time-honored her in 1999 as one of its “Digital 50.” She also served as a White House Commissioner on Libraries and Information Science during the Clinton administration, and she has conducted hearings on aging and technology for the U.S. Senate. She was named one of the 100 most influential women in Silicon Valley by the Silicon Valley Business Journal and has been a recipient of the ASA Leadership Award. Mary is an advisory member of the Ziegler Link•age Longevity Fund, L.P.
Mary is the author of Turning Silver into Gold: How to Profit in the New Boomer Marketplace, which was published in February 2007 by Financial Times Press. She also co-authored the book Grown-Up’s Guide to Computing, published by Microsoft Press in 1999.
By Rory McCann, Marketing Manager & Conference Producer, LSN
Life Science Nation (LSN) is a proud partner of The Children’s Tumor Foundation (CTF) and their mission to drive research, expand knowledge, and advance care for those suffering from Neurofibromatosis (NF). We sat down with CTF President, Dr. Annette Bakker and Vice President of Development, Barbara Gallagher to discuss CTF’s work in the NF community, including the upcoming Hack for NF hackathon, taking place October 2-November 13, 2020, as well as Dr. Bakker’s participation on the AI and Precision Medicine Investments panel at the digital partnering conference, 4D Meets AI, taking place next week – September 17-18, 2020.
Listen to our conversation as we discuss the role of foundations like CTF in scientific research and healthcare innovation.
Annette Bakker, PhD, President, The Children’s Tumor Foundation (CTF)
Annette Bakker, the Children’s Tumor Foundation’s President, holds a PhD in cell biology from the University of Antwerp. Her past experience includes serving as Oncology Group Leader at Janssen Pharmaceutica, and postdoctoral fellowships at Yale University and La Salpetriere, Paris. Before joining the Children’s Tumor Foundation, Dr. Bakker served as head of the Oncology R&D department for a biotech company in Siena, Tuscany. While there, she designed and created a neuro-oncology department from the ground up, and managed large oncology research initiatives both nationally (Italian networks) and internationally (European and Asian networks). Dr. Bakker’s research has been internationally recognized by more than 30 peer-reviewed papers, patents, and awards, and she has extensive experience liaising and negotiating with biotechnology and pharmaceutical companies. In her role at the Children’s Tumor Foundation, Annette and her team will continue to build a strong NF community, design and execute innovative business models to accelerate the path from basic discovery to clinical benefit for NF patients, develop partnerships with pharmaceutical and biotech industries, and attract new scientists and funders to the NF field. Annette is originally from Belgium, and speaks four languages (English, French, Dutch, and Italian). She lives happily in Westchester, NY with her family.
Barbara Gallagher, Vice President, Development, The Children’s Tumor Foundation (CTF)
Senior executive with expertise in non-profit management, strategic planning, fundraising, sponsorship, events, volunteer engagement, major gifts and communications. Results-oriented leader with established track record of building collaborative relationships with Board members, volunteer leaders, donors and corporate partners resulting in campaign revenue milestones. Experienced manager with the ability to coach and develop staff in different roles across an organization.
Next Phase Newsletter 